Medical Countermeasures UK Opens Moderna mRNA Vaccine Centre in Oxfordshire and Launches £50 Million Life-Sciences FundGlobal Biodefense StaffSeptember 29, 2025
Contracts + Grants U.S. Expands Investments in Biodefense Preparedness Through New Medical Countermeasure ContractsGlobal Biodefense StaffSeptember 23, 2025
Pathogens New Study Reveals Key to Marburg and Ebola Virus Assembly, Opening Door to Broad-Spectrum AntiviralsGlobal Biodefense StaffSeptember 23, 2025
New Monoclonal Antibodies Offer Hope for Universal Influenza Treatment Medical Countermeasures May 1, 2025 …
Innovative VLP-Based Vaccine Shows Promise Against Avian Influenza Medical Countermeasures April 30, 2025 …
Federal Scientists Use AI to Optimize Antibodies Against Mutations Medical Countermeasures April 7, 2025 …
W.H.O. Partner Program Allocates 238,000 Doses of Mpox Vaccine to Four Countries Medical Countermeasures March 19, 2025 …
Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical Countermeasures Medical Countermeasures March 18, 2025 …
Tecovirimat Shown to Lack Efficacy as Treatment for Clade II Mpox Medical Countermeasures March 12, 2025 …
Bolstering Pandemic Preparedness: HHS Funds Accelerated Development of H5N1 Vaccine Medical Countermeasures January 17, 2025 …
FDA Removes Clinical Hold on Novavax’s Combo COVID-Flu Vaccine Medical Countermeasures November 11, 2024 …
Humanetics Presents BIO 300 Radiation Countermeasure Data at DoD Scientific Meeting Medical Countermeasures October 3, 2024 …
GigaGen Wins BARDA Contract to Develop Biothreat Countermeasures Medical Countermeasures October 3, 2024 …
Acurx Announces Anthrax Susceptibility to ACX-375 Analogues Medical Countermeasures September 26, 2024 …
New Partnerships Boost Decentralized Clinical Trial Capacity for Public Health Emergencies Contracts + Grants August 27, 2024 …
Disappointing Results for Tecovirimat Mpox Trial in the DRC Medical Countermeasures August 15, 2024 …
Lassa Fever Vaccine Study Supports Advancement to Phase I Trial Medical Countermeasures August 14, 2024 …
Thylacine Biotherapeutics Earns Top Honor in Medical Threat Reduction Challenge Medical Countermeasures July 9, 2024 …
Maxwell Biosciences Enters CRADA with USAMRIID to Test Potential Therapeutics Industry News May 8, 2024 …
RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035 Medical Countermeasures May 6, 2024 …
